MedPath

Dexmedetomidine Hydrochloride

These highlights do not include all the information needed to use DEXMEDETOMIDINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DEXMEDETOMIDINE HYDROCHLORIDE INJECTION. DEXMEDETOMIDINE HYDROCHLORIDE injection for intravenous useInitial U.S. Approval: 1999

Approved
Approval ID

4fe788bc-4ad1-4b32-83d3-dcbfcd8429aa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 20, 2018

Manufacturers
FDA

Sun Pharmaceuticals Industries, Inc.

DUNS: 146974886

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DEXMEDETOMIDINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57664-596
Application NumberANDA202126
Product Classification
M
Marketing Category
C73584
G
Generic Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 20, 2018
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXMEDETOMIDINE HYDROCHLORIDEActive
Quantity: 100 ug in 1 mL
Code: 1018WH7F9I
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexmedetomidine Hydrochloride - FDA Drug Approval Details